AI English summary of an SEC filing — figures as filed
Northrop Grumman NOCThe company said full-year 2023 sales rose 7% to $39.3 billion, and fourth-quarter sales rose 6% to $10.6 billion. The company posted a net loss of $535 million for Q4 ($3.54 loss per diluted share), while full-year net earnings were $2.1 billion ($13.53 per diluted share).
Key points
AI summaryThe company said full-year 2023 sales rose 7% to $39.3 billion, and fourth-quarter sales rose 6% to $10.6 billion. The company posted a net loss of $535 million for Q4 ($3.54 loss per diluted share), while full-year net earnings were $2.1 billion ($13.53 per diluted share).
The company said it recognized a pre-tax charge of $1.56 billion on the LRIP phase of the B-21 program in Q4. It said the after-tax charge is $1.17 billion, or $7.68 per diluted share for the full year. The company also said it determined that it is probable the first 5 LRIP lots will be performed at a loss.
Northrop Grumman said operating cash flow for 2023 rose 34% to $3,875 million, and adjusted free cash flow rose 30% to $2,100 million. The company cited improved trade working capital, driven by higher billings and cash collections, as the factor behind the increase in operating cash flow.
The company provided 2024 guidance for sales of $40,800 million to $41,200 million, segment operating income of $4,475 million to $4,550 million, and free cash flow of $2,250 million to $2,650 million. It said MTM-adjusted EPS is expected to be $24.45 to $24.85.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
Full-Year 2023 and Q4 Sales; Q4 Net Loss
The company said full-year 2023 sales rose 7% to $39.3 billion, and fourth-quarter sales rose 6% to $10.6 billion. The company posted a net loss of $535 million for Q4 ($3.54 loss per diluted share), while full-year net earnings were $2.1 billion ($13.53 per diluted share).
Source · Based on the filing body and exhibits
B-21 LRIP Phase $1.56 billion Pre-Tax Charge
The company said it recognized a pre-tax charge of $1.56 billion on the LRIP phase of the B-21 program in Q4. It said the after-tax charge is $1.17 billion, or $7.68 per diluted share for the full year. The company also said it determined that it is probable the first 5 LRIP lots will be performed at a loss.
Source · Based on the filing body and exhibits
2023 Operating Cash Flow and Adjusted Free Cash Flow
Northrop Grumman said operating cash flow for 2023 rose 34% to $3,875 million, and adjusted free cash flow rose 30% to $2,100 million. The company cited improved trade working capital, driven by higher billings and cash collections, as the factor behind the increase in operating cash flow.
Source · Based on the filing body and exhibits
2024 Guidance
The company provided 2024 guidance for sales of $40,800 million to $41,200 million, segment operating income of $4,475 million to $4,550 million, and free cash flow of $2,250 million to $2,650 million. It said MTM-adjusted EPS is expected to be $24.45 to $24.85.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…